Yuka Igarashi
Yokohama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Gut microbiome functional pathways outperform taxonomic profiles in predicting immune checkpoint inhibitor response in non-small cell lung cancer: an interpretable machine learning approach with SHAP.
Journal: Frontiers in immunology
Published: March 17, 2026
Machine learning-based insights into circulating autoantibody dynamics and treatment outcomes in patients with NSCLC receiving immune checkpoint inhibitors.
Journal: Frontiers in immunology
Published: July 15, 2025
Characteristics and clinical significance of immune cells in omental milky spots of patients with gastric cancer.
Journal: Frontiers in immunology
Published: November 01, 2024
Human iPSC-derived NK cells armed with CCL19, CCR2B, high-affinity CD16, IL-15, and NKG2D complex enhance anti-solid tumor activity.
Journal: Stem cell research & therapy
Published: July 08, 2024
Prognostic Significance of Plasma Neutrophil Extracellular Trap Levels in Patients with Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors.
Journal: Biomedicines
Published: July 04, 2024
Mental health of divorcees through divorce by mutual consent in Japan.
Journal: PCN reports : psychiatry and clinical neurosciences
Published: May 08, 2024
Multi-omics analysis-based clinical and functional significance of a novel prognostic and immunotherapeutic gene signature derived from amino acid metabolism pathways in lung adenocarcinoma.
Journal: Frontiers in immunology
Published: December 27, 2023
Circulating IL-6 and not its circulating signaling components sIL-6R and sgp130 demonstrate clinical significance in NSCLC patients treated with immune checkpoint inhibitors.
Journal: Frontiers in cell and developmental biology
Published: October 20, 2023
MMP1, IL-1β, sTNFR-1, and IL-6 are prognostic factors for patients with unresectable or metastatic renal cell carcinoma treated with immune checkpoint inhibitors.
Journal: International journal of clinical oncology
Published: September 28, 2023
Immune mediators as predictive biomarkers for anti-PD-1 antibody therapy in urothelial carcinoma.
Journal: Frontiers in pharmacology
Published: July 31, 2023
Machine learning for prediction of immunotherapeutic outcome in non-small-cell lung cancer based on circulating cytokine signatures.
Journal: Journal for immunotherapy of cancer
Published: June 11, 2023
Clinical roles of soluble PD-1 and PD-L1 in plasma of NSCLC patients treated with immune checkpoint inhibitors.
Journal: Cancer immunology, immunotherapy : CII
Published: December 24, 2022
Last Updated: 09/26/2026